Findings in the Area of Solid Cancer Reported from Mayo Clinic (Phase 1 Trial of Navitoclax and Sorafenib In Patients With Relapsed or Refractory Solid Tumors With Hepatocellular Carcinoma Expansion Cohort)

Media coverage

• Title	Findings in the Area of Solid Cancer Reported from Mayo Clinic (Phase 1 Trial of Navitoclax and Sorafenib In Patients With Relapsed or Refractory Solid Tumors With Hepatocellular Carcinoma Expansion Cohort)
  Media name/outlet	Clinical Trials Daily
  Country/Territory	United States
  Date	28/02/24
  Persons	Gary Schwartz